Since both these diseases share with COVID-19 an inflammatory basis, this drug has been indicated as a potential therapeutic candidate [160,161]
Healthcare strategies to combat PASC, the novel virus-induced human metabolic syndrome, requires an in-depth understanding of the following: (i) the genomic and metabolomic (proteomic/lipidomic) signatures of SARS-CoV-2 and their interactions with host cellular metabolic machinery, (ii) the virus-induced HMRD and resulting pathophysiological manifestations in the onset and progression of COVID-19, (iii) the cumulative role of HMRD, symptomatic outcomes (disease spectrum), and comorbidities in systemic/multi-organ dysfunction during COVID-19, (iv) both virus- and host-mediated factors that contribute to transition of acute SARS-CoV-2 infection (COVID-19) into a persistent chronic state of virus-free PASC, (v) protracted effects of HMRD in tandem with patients history, in the development of new onset metabolic syndromes (i.e., T2DM, CVD, ME/CFS and POTS) among PASC patients, (vi) stratification/categorization of PASC patients based on persistent symptoms, organ/system involvement, and metabolic dysfunction for specific target-delivered health recovery regimens, and (vii) the structure-function activity of specific bio-functional dietary compounds in formulating precision nutrition protocols to reset SARS-CoV-2-induced HMRD in chronic PASC
Key physiological effects include: Elevated basal metabolic rate (BMR) Enhanced mitochondrial efficiency and endurance Fat loss while preserving lean muscle mass For a full breakdown of NNMT inhibition, NAD preservation, and the role of SIRT1, see 5-Amino-1MQ for Beginners: Dosage, Benefits, and Peptide Stacks Explained
For best results, supplements should be taken under the supervision of healthcare professionals who can recommend the right dosage and formulation based on individual health goals
alpha-Tocopherol at Nanomolar Concentration Protects Cortical Neurons against Oxidative Stress
